"Sidney Kimmel Cancer Center – Jefferson Health is a National Cancer Institute-designated cancer center located in Philadelphia, PA. Our mission is to improve the lives of cancer patients and their families through compassion, innovation and breakthrough discoveries."

During the past decade, Kimmel Cancer Center at Thomas Jefferson University - Philadelphia conducted 123 clinical trials. In the 10-year time frame, 123 clinical trials started and 69 clinical trials were completed, i.e. on average, 56.1% percent of trials that started reached the finish line to date. In the past 5 years, 62 clinical trials started and 19 clinical trials were completed. i.e. 30.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia" #1 sponsor was "Radiation Therapy Oncology Group" with 76 trials, followed by "Sidney Kimmel Cancer Center at Thomas Jefferson University" with 60 trials sponsored, "Thomas Jefferson University" with 39 trials sponsored, "Gynecologic Oncology Group" with 34 trials sponsored and "Eastern Cooperative Oncology Group" with 34 trials sponsored. Other sponsors include 101 different institutions and companies that sponsored additional 56 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia" #1 collaborator was "National Cancer Institute (NCI)" with 195 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Bristol-Myers Squibb" with 10 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator and "North Central Cancer Treatment Group" with 9 trials as a collaborator. Other collaborators include 86 different institutions and companies that were collaborators in the rest 57 trials.

According to Clinical.Site data, the most researched conditions in "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia" are "Breast Cancer" (31 trials), "Lung Cancer" (28 trials), "Prostate Cancer" (23 trials), "Head and Neck Cancer" (22 trials) and "Ovarian Cancer" (21 trials). Many other conditions were trialed in "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia" in a lesser frequency.

Most popular intervention types in "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia" are "Drug" (233 trials), "Radiation" (110 trials), "Procedure" (96 trials), "Other" (64 trials) and "Biological" (57 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (57 trials), "cisplatin" (37 trials), "paclitaxel" (29 trials), "conventional surgery" (16 trials) and "docetaxel" (14 trials). Other intervention names were less common.

The vast majority of trials in "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia" are 229 trials for "All" genders, 72 trials for "Female" genders and 34 trials for "Male" genders.

Currently, there are NaN active trials in "Kimmel Cancer Center at Thomas Jefferson University - Philadelphia". 2 are not yet recruiting, 53 are recruiting, 34 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 195 completed trials in Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, 2 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Kimmel Cancer Center at Thomas Jefferson University - Philadelphia, 58 "Phase 1" clinical trials were conducted, 150 "Phase 2" clinical trials and 89 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 45 trials that are defined as “Not Applicable".